Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.

Compounds and their pharmaceutically acceptable salts for treatment of tauopathies, such as Alzheimer's disease, Pick's disease, progressive supranuclear palsy, corticobasal degeneration, familial frontotemporal dementia/Parkinsonism linked to chromosome 17, amyotrophic lateral sclerosis/Parkinsonism-dementia complex, argyrophilic grain dementia, dementia pugilistic, diffuse neurofibrillary tangles with calcification, progressive subcortical gliosis and tangle only dementia.

The present application describes process for preparing an ortho-allylated hydroxy aryl compounds such as compounds of Formula (I) by reacting an allylic alcohol with a hydroxy aryl compound in the presence of aluminum compound selected from alumina and aluminum alkoxides and in a non-protic solvent wherein at least one carbon atom ortho to the hydroxy group in the hydroxy aryl compound is unsubstituted. The present application also includes compounds of Formula (I). ##STR00001##

The present application describes process for preparing an ortho-allylated hydroxy aryl compounds such as compounds of Formula (I) by reacting an allylic alcohol with a hydroxy aryl compound in the presence of aluminum compound selected from alumina and aluminum alkoxides and in a non-protic solvent wherein at least one carbon atom ortho to the hydroxy group in the hydroxy aryl compound is unsubstituted. The present application also includes compounds of Formula (I). ##STR00001##

The present application describes process for preparing an ortho-allylated hydroxy aryl compounds such as compounds of Formula (I) by reacting an allylic alcohol with a hydroxy aryl compound in the presence of aluminum compound selected from alumina and aluminum alkoxides and in a non-protic solvent wherein at least one carbon atom ortho to the hydroxy group in the hydroxy aryl compound is unsubstituted. The present application also includes compounds of Formula (I).

##STR00001##

The present application describes process for preparing an ortho-allylated hydroxy aryl compounds such as compounds of Formula (I) by reacting an allylic alcohol with a hydroxy aryl compound in the presence of aluminum compound selected from alumina and aluminum alkoxides and in a non-protic solvent wherein at least one carbon atom ortho to the hydroxy group in the hydroxy aryl compound is unsubstituted. The present application also includes compounds of Formula (I).

##STR00001##

An organic positive electrode active material for aqueous redox flow batteries, and more particularly, to technology of applying an organic positive electrode active material to make up for the drawbacks of conventional aqueous redox flow batteries. An aqueous redox flow battery to which a particular positive electrode active material is applied has no problems regarding metal deposition, and can also be useful in realizing a high energy density because the positive electrode active material may be used at high concentration due to an increase in solubility in a solvent, attaining a high working voltage, and enhancing energy efficiency. Also, the aqueous redox flow battery has excellent economic feasibility because an expensive organic electrolyte is not used.

An organic positive electrode active material for aqueous redox flow batteries, and more particularly, to technology of applying an organic positive electrode active material to make up for the drawbacks of conventional aqueous redox flow batteries. An aqueous redox flow battery to which a particular positive electrode active material is applied has no problems regarding metal deposition, and can also be useful in realizing a high energy density because the positive electrode active material may be used at high concentration due to an increase in solubility in a solvent, attaining a high working voltage, and enhancing energy efficiency. Also, the aqueous redox flow battery has excellent economic feasibility because an expensive organic electrolyte is not used.

A continuous paracetamol preparation method, including a nitration step or a nitrosation step to obtain p-nitrophenol or p-nitrosophenol respectively. P-nitrophenol or p-nitrosophenol can then be converted into paracetamol by hydrogenation, followed by acylation. This continuous paracetamol preparation method makes it possible to obtain paracetamol with a very good regioselectivity and excellent yields.

A continuous paracetamol preparation method, including a nitration step or a nitrosation step to obtain p-nitrophenol or p-nitrosophenol respectively. P-nitrophenol or p-nitrosophenol can then be converted into paracetamol by hydrogenation, followed by acylation. This continuous paracetamol preparation method makes it possible to obtain paracetamol with a very good regioselectivity and excellent yields.